Repligen (RGEN) Earnings Date & Reports

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGEN is expected to report earnings to fall 14.31% to 46 cents per share on November 03

Q3'26

Est.

$0.46

Q2'26

Beat

by $0.09

Q1'26

Beat

by $0.10

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.04

The last earnings report on July 28 showed earnings per share of 54 cents, beating the estimate of 44 cents. With 833.02K shares outstanding, the current market capitalization sits at 9.38B.

View a ticker or compare two or three

RGEN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days